IBRANCE caps 75 mg 21 pce
7680661380012
CH-66138
L01EF01
07.16.1.
Reimbursement limitations:
IBRANCE.01a
Pour le traitement des femmes ménopausées atteintes d’un cancer du sein localement avancé ou métastatique, …
1 / 3
google
Details
- Product number
- 6613801
- CPT
- -
- Packaging group
- 21
- Unit
- Kapsel(n)
- Composition
- palbociclibum 75 mg, cellulosum microcristallinum, lactosum monohydricum 55.775 mg, carboxymethylamylum natricum A, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 172 (rubrum), E 172 (flavum), E 171, Drucktinte: lacca, E 171, ammoniae solutio 28 per centum, propylenglycolum, simeticonum, pro capsula, natrium 1.28 mg.
Articles (1)
Ibrance 75 mg, Hartkapseln
Kapseln
21
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
75.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
55.775 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.28 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 2162.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2017
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 66138
- Drug name
- Ibrance, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- L01EF01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 31/01/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- IBRANCE caps 75 mg 21 pce
- Description (DE)
- IBRANCE Kaps 75 mg 21 Stk
- Market launch
- 31/01/2017
- Narcotic (BTM)
- No